Emerging and Zoonotic Diseases Signature Program

As we enter the 21st century, infectious diseases continue to burden populations around the world. New infectious diseases continue to emerge, and older ones that were well controlled re-emerge. Approximately 75% of all emerging or re-emerging infectious diseases are zoonotic. Naturally as well as intentionally introduced biological agents increasingly threaten to cause disease, disability, and death. And beyond disease itself, infectious agents have the ability to destabilize populations, economies, and governments.

We must replace the resources and people trained in basic science of emerging and zoonotic infectious diseases that were lost during the 1960s and 1970s, and the College's faculty's expertise in basic, applied, and clinical research, and emerging and zoonotic diseases is critical to fill this need. Research in the College advances our basic understanding of the pathogenesis of emerging and zoonotic diseases, and develops novel and targeted surveillance systems, new diagnostic reagents and tests, and new vaccines and therapeutic agents to treat and prevent emerging and zoonotic diseases.  

Steering Committee Members

Pamela Skinner, VBS (lead)
Carol Cardona, VBS
Tim Johnson, VBS
Maxim Cheeran, VPM
Yuying Liang, VBS 

Funding Opportunities and Awards

Click here for information regarding Emerging and Zoonotic Diseases Signature Program funding opportunities and to learn more about grants that have been awarded recently. If you have any questions please contact the lead of the Steering Committee or the CVM Research Office.

  • ©2014 Regents of the University of Minnesota. All rights reserved.
  • The University of Minnesota is an equal opportunity educator and employer
  • Last modified on September 5, 2014